Trade Axcelis - ACLS CFD

Market is not available at the momentMarket information is presented
as of 2026-10-09T19:47:23+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.71
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022179 %
(-$4.44)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02218%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000043 %
(-$0.01)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00004%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close133.19
Open136.59
1-Year Change61.68%
Day's Range132.87 - 136.59

Trade Axcelis - ACLS

About Axcelis Technologies Inc

Axcelis Technologies, Inc. designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. It offers a complete line of high energy, high current and medium current implanters for all application requirements. Its Purion systems are all based on a common platform, which enables a combination of implant purity, precision and productivity. Its Purion H, Purion Dragon and Purion H200 spot beam, high current systems cover all high current requirements. Its Purion XE high energy system combines its radio frequency (RF) Linac high energy, spot beam technology with the Purion platform wafer handling system. It also offers the Purion M medium current system. Its Purion M systems also offer differentiated capabilities for specialty applications.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Axcelis Technologies Inc revenues increased 40% to $662.4M. Net income increased 97% to $98.7M. Revenues reflect Ion Implantation Systems Services And Royalties segment increase of 41% to $645.5M, United States segment increase of 48% to $519.4M, Asia Pacific segment increase of 13% to $106.4M. Net income benefited from Interest on lease liabilities decrease of 2% to $5.1M (expense).

Equity composition

Common Stock $.001 Par, 12/10, 300M auth., 105,906,000 issd, 120,000 Treas. @ cost $1.2M.Insiders own 1.82%. InitialPublic Offering 7/11/00, 15.5M shares @ $22 by Goldman,Sachs & Co. *12/29/00, Eaton corporation distributed its remaining 82% interest in the form of a spin-off to Eaton shareholders (80M shares).

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready